<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02270853</url>
  </required_header>
  <id_info>
    <org_study_id>13-136</org_study_id>
    <nct_id>NCT02270853</nct_id>
  </id_info>
  <brief_title>SAS in Patients With Bronchial Carcinoma</brief_title>
  <acronym>SAS CA</acronym>
  <official_title>Incidence of Sleep Apnea Syndrome (SAS) in Patients With Bronchial Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study it will be analyzed how often the sleep apnea syndrome can be observed in
      patients with newly diagnosed lung cancer with the help of ApneaLink device by ResMed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Determination of the SAS- frequence in patients with bronchial carcinoma. The patients will
      be screened at home for 1 night with the ApneaLink device by ResMed. The apneaLink device is
      a standard screening tool for sleep apnea in clinical practice.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percent of sleep apnea in patients with bronchial carcinoma</measure>
    <time_frame>two days</time_frame>
    <description>The percent of sleep apnea in a cohort of patients with bronchial carcinoma will be evaluated. The duration of the study participation is two days.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Sleep Apnea Syndrome</condition>
  <condition>Bronchial Carcinoma</condition>
  <arm_group>
    <arm_group_label>sleep apnea screening with ApneaLinkTM</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This is the only group in the present study. Patients with bronchial carcinoma (or reasonable suspicion) perform sleep screening with ApneaLinkTM at home or during the hospitalization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sleep apnea screening with ApneaLinkTM</intervention_name>
    <description>ApneaLink is sleep-screening tool that objectively identifies patients with sleep apnea</description>
    <arm_group_label>sleep apnea screening with ApneaLinkTM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with reasonable suspicion of bronchial carcinoma or histologically proven
             bronchial carcinoma, which has not been medicated until the study entry and

          -  Patients with sleep apnea who had recently been diagnosed with bronchial carcinoma.

        Exclusion Criteria:

          -  Pregnancy

          -  other already known malignancies or tumors

          -  Patients with non-invasive artificial respiration due to a chronic respiratory
             insufficiencies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Dreher, Univ.-Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>RWTH Aachen University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Angela Habier</last_name>
    <phone>0492418037429</phone>
    <email>ahabier@ukaachen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medizinische Klinik I Uniklinik RWTH Aachen</name>
      <address>
        <city>Aachen</city>
        <state>NRW</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Dreher, Univ.-Prof.</last_name>
      <phone>+49 241 80 37127</phone>
    </contact>
    <contact_backup>
      <last_name>Tobias Müller, PD Dr. med.</last_name>
      <phone>+49 241 80 37127</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Merheim</name>
      <address>
        <city>Köln</city>
        <state>NRW</state>
        <zip>51109</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hendrik Storre, PD.Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Florence-Nightingale Hospital</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40489</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krüger Stefan, Prof.</last_name>
      <phone>0211/ 409 3441</phone>
      <email>stkrueger@kaiserswerther-diakonie.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2014</study_first_submitted>
  <study_first_submitted_qc>October 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2014</study_first_posted>
  <last_update_submitted>February 17, 2016</last_update_submitted>
  <last_update_submitted_qc>February 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ApneaLink</keyword>
  <keyword>bronchial carcinoma</keyword>
  <keyword>sleep apnea screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Carcinoma, Bronchogenic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

